Halozyme and Incyte sign drug delivery licensing agreement
Go back to Halozyme and Incyte sign drug delivery licensing agreement| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 109.22 -0.97 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $110.19 | 52 Week High | $18.39 | |||
| Open | $109.00 | 52 Week Low | $6.96 | |||
| Day High | $109.96 | P/E | N/A | |||
| Day Low | $106.07 | EPS | $-0.58 | |||
| Volume | 899,652 | |||||
| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 126.20 -0.55 (0.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $126.75 | 52 Week High | $118.49 | |||
| Open | $124.11 | 52 Week Low | $55.00 | |||
| Day High | $126.40 | P/E | N/A | |||
| Day Low | $122.22 | EPS | $-0.56 | |||
| Volume | 570,220 | |||||
